Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ajith Sominanda"'
Autor:
Keerthie Dissanayake, Chandrika Jayasinghe, Priyani Wanigasekara, Jayampathy Dissanayake, Ajith Sominanda
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0278285 (2022)
Routine use of the Disease Activity Score-28 (DAS28) to assess the disease activity in rheumatoid arthritis (RA) is limited due to its dependency on laboratory investigations and the complex calculations involved. In contrast, the clinical disease ac
Externí odkaz:
https://doaj.org/article/3f657885070f48bd8287d78315662e2f
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0246111 (2021)
Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and 'treat to the target.' However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines, a d
Externí odkaz:
https://doaj.org/article/c9a8a835884b4bb3aeca0e8dafb67d67
Publikováno v:
Qatar Medical Journal. 2023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a4e5794074631e128e929afe1208e46
https://doi.org/10.5339/qmj.2023.sqac.13
https://doi.org/10.5339/qmj.2023.sqac.13
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0246111 (2021)
PLoS ONE
PLoS ONE
Biomarkers play a pivotal role in the management of rheumatoid arthritis (RA) by facilitating early diagnosis and ‘treat to the target.’ However, no gold standard biomarker has been identified for monitoring the disease activity in RA. Cytokines,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc777d9aad097c75e593d865ede5cfe
https://doaj.org/article/c9a8a835884b4bb3aeca0e8dafb67d67
https://doaj.org/article/c9a8a835884b4bb3aeca0e8dafb67d67
Autor:
S. M. K. Gamage, Katharina Fink, Herath Mudiyanselage Ajith Sominanda, Priyangi Wijesinghe, S. B. Adikari, Indunil Wijeweera
Publikováno v:
Journal of Clinical Neurology (Seoul, Korea)
BACKGROUND AND PURPOSE The magnetic resonance imaging in multiple sclerosis (MAGNIMS) group recently proposed guidelines to replace the existing dissemination-in-space criteria in McDonald 2010 magnetic resonance imaging (MRI) criteria for diagnosing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2df278145a78ffb3e3daf4531e1196
https://pubmed.ncbi.nlm.nih.gov/29856160
https://pubmed.ncbi.nlm.nih.gov/29856160
Autor:
Roger Jungedal, Elin Engdahl, Jan Hillert, Ryan Ramanujam, Anna Fogdell-Hahn, Ajith Sominanda, Malin Lundkvist, Helga Westerlind
Publikováno v:
Multiple Sclerosis Journal. 18:1775-1781
Background: Neutralizing antibodies (NAbs) against interferon beta (IFNβ) lead to loss of treatment efficacy in multiple sclerosis patients. The seroprevalence of NAbs in multiple sclerosis patients treated with IFNβ during 2003–2004 was 32% in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be739c728a1a475ace81f417229b5eff
https://doi.org/10.1177/1352458512446036
https://doi.org/10.1177/1352458512446036
Autor:
Anna Fogdell-Hahn, Anna Steinberg, Christina Sjöstrand, Ajith Sominanda, A. I. M. Nilsson Remahl
Publikováno v:
Acta Neurologica Scandinavica. 124:130-134
Steinberg A, Sjostrand C, Sominanda A, Fogdell-Hahn A, Nilsson Remahl AIM. Interleukin-2 gene expression in different phases of episodic cluster headache – a pilot study. Acta Neurol Scand: 2011: 124: 130–134. © 2010 John Wiley & Sons A/S. Backg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b83bb2d01c5aac1ffca27a4c312bdbd
https://doi.org/10.1111/j.1600-0404.2010.01434.x
https://doi.org/10.1111/j.1600-0404.2010.01434.x
Publikováno v:
Multiple Sclerosis Journal. 13:208-214
Development of neutralizing antibodies (NAbs) reduces the clinical efficacy of interferon beta (IFNβ) treatment in multiple sclerosis (MS) patients. The aim of this study was to evaluate NAb seroprevalence (frequency of patients with NAbs) and immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139128adc9c32d57a18c6389adad6b63
https://doi.org/10.1177/1352458506070762
https://doi.org/10.1177/1352458506070762
Autor:
Anna Fogdell-Hahn, Jan Hillert, Ajith Sominanda, Bernhard Hemmer, Hans-Peter Hartung, Malin Lundkvist, Til Menge, Bernd C. Kieseier
Publikováno v:
Archives of Neurology. 67
Objective To determine if neutralizing antibodies (NAbs) against interferon beta from patients with multiple sclerosis (MS) cross-react with other type 1 interferons, especially endogenous interferon beta, and thus might impede the immune systems of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71006ce9dec4083043f7586bb3413125
https://doi.org/10.1001/archneurol.2010.218
https://doi.org/10.1001/archneurol.2010.218